Development of dual responsive nanocomposite for simultaneous delivery of anticancer drugs

Development of dual responsive nanocomposite for simultaneous delivery of anticancer drugs


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: رویا صالحی قره ورن , حامد همیشه کار , مرتضی اسکندانی , سودابه داوران

کلمات کلیدی: Cancer, dual drug delivery, nanoparticles, stimuli-responsive, targeted delivery

نشریه: 17392 , 4 , 22 , 2014

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله رویا صالحی قره ورن
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه مرکز تحقیقات کاربردی دارویی
کد مقاله 71380
عنوان فارسی مقاله Development of dual responsive nanocomposite for simultaneous delivery of anticancer drugs
عنوان لاتین مقاله Development of dual responsive nanocomposite for simultaneous delivery of anticancer drugs
ناشر 5
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ بلی
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

In this paper novel stimuli-responsive cationic mesoporous silica nanoparticles (MSNs) were fabricated through the facile polymerization method. The synthesis process was characterized and validated by Fourier transform infrared spectroscopy and hydrogen nuclear magnetic resonance spectroscopy. The prepared nanoparticles were characterized using scanning electron microscopy (SEM), Zeta potential and thermogravimetric analysis methods. SEM results revealed the uniformity in size and shape of nanoparticles with a mean diameter of approximately 60 nm. Two model anticancer drugs, Doxorubicin (DOX) and Methotroxate (MTX) were loaded effectively to functionalized MSNs through electrostatic interactions. Our developed HPLC-UV method was applied for simultaneous determination of DOX and MTX. Modified MSNs yielded a pH and temperature-triggered release of entrapped drugs at tumor tissue environment (lower pH and higher temperature than physiological condition). In-vitro cytotoxicity assay showed that the blank carrier showed no cytotoxicity on both A549 and MCF7 cells at different amounts after incubation for 72 h confirming its suitability as a drug carrier. Multi anticancer drug-loaded MSNs, in the other hand, caused an efficient anticancer performance verified by DAPI staining and MTT assay tests. It was concluded that our findings may open the possibilities for cooperative thermo and pH-responsive targeted delivery of DOX and MTX to the cancerous tissues.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
رویا صالحی قره ورناول
حامد همیشه کاردوم
مرتضی اسکندانیسوم
سودابه داورانپنجم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
13-J Drug Target, 2014.pdf1398/12/162312110دانلود